1. Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD Study. Issue 3 (September 2021) Authors: Levy, Jerrold H.; van Ryn, Joanne; Sellke, Frank W.; Reilly, Paul A.; Elsaesser, Amelie; Glund, Stephan; Kreuzer, Jörg; Weitz, Jeffrey I.; Pollack, Charles V. Journal: Annals of surgery Issue: Volume 274:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals. Issue 7 (6th April 2022) Authors: Agarwal, Rajiv; Hauske, Sibylle Jenny; Wheeler, David C.; Doi, Kent; Elsaesser, Amelie; Ritter, Ivana; Steubl, Dominik; Wanner, Christoph Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 7(2022) Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding. Issue 6 (5th February 2019) Authors: Van der Wall, Sake J.; Lopes, Renato D.; Aisenberg, James; Reilly, Paul; van Ryn, Joanne; Glund, Stephan; Elsaesser, Amelie; Klok, Frederikus A.; Pollack, Charles V.; Huisman, Menno V. Journal: Circulation Issue: Volume 139:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗